These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 261887

  • 1. [Evaluation of the electrophysiological properties of atenolol and of the combination of quinidine and atenolol in humans].
    Capucci A, Verardi P, Binetti G, Bracchetti D, Ambrosioni E, Magnani B.
    Boll Soc Ital Cardiol; 1979; 24(10):1059-64. PubMed ID: 261887
    [No Abstract] [Full Text] [Related]

  • 2. [The treatment of acute cardiac dysrhythmias with atenolol (Tenormin) particularly after myocardial infarction (author's transl)].
    Schley G, Beckmann R, Hengstebeck W.
    Z Kardiol; 1978 Apr; 67(4):280-8. PubMed ID: 77592
    [No Abstract] [Full Text] [Related]

  • 3. The pharmacology of Norpace.
    Dean RR.
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract] [Full Text] [Related]

  • 4. The electrophysiology of Norpace (Part II).
    Befeler B.
    Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
    [No Abstract] [Full Text] [Related]

  • 5. Combined use of digitalis and propranolol HCl.
    Dreifus LS.
    Am Fam Physician; 1974 Jan; 9(1):178-81. PubMed ID: 4809762
    [No Abstract] [Full Text] [Related]

  • 6. [Association of LB 46-quinidine in the treatment of chronic atrial fibrillation. Electrocardiographic aspects of persons with restored sinus rhythm].
    Proto C, Levi GP, Quadri A, Levi GF.
    Minerva Med; 1971 Jul 11; 62(55):2772-6. PubMed ID: 5563926
    [No Abstract] [Full Text] [Related]

  • 7. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS.
    Cardiovasc Clin; 1970 Jul 11; 2(2):211-37. PubMed ID: 4149974
    [No Abstract] [Full Text] [Related]

  • 8. [Retardation of the excitation conduction by propaphenone. Duration and dosage effect relation after oral administration (author's transl)].
    Beck OA, Abdulla S, Hochrein H.
    MMW Munch Med Wochenschr; 1975 Aug 29; 117(35):1369-72. PubMed ID: 809677
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic basis for the treatment of cardiac arrhythmias.
    Gelband H, Rosen MR.
    Pediatrics; 1975 Jan 29; 55(1):59-67. PubMed ID: 1089243
    [No Abstract] [Full Text] [Related]

  • 10. [Therapy of lidocaine-resistant arrhythmias following experimentally severe heart infarct by supplementary sympathicolysis, especially with atenolol].
    Abendroth RR, Hübner H, Stephan K, Meesmann W.
    Verh Dtsch Ges Inn Med; 1975 Jan 29; 83():211-5. PubMed ID: 77107
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of heart arrhythmias with calcium antagonists].
    Bender F.
    Z Kardiol; 1984 Jan 29; 73 Suppl 2():101-5. PubMed ID: 6084911
    [Abstract] [Full Text] [Related]

  • 12. [Dose-related effect of nicainoprol (CAS 924) on basic electrophysiologic parameters in patients with and without diseases of the heart conduction system].
    Sen S, Rettig G, Schieffer H, Bette L.
    Z Kardiol; 1988 Sep 29; 77(9):600-7. PubMed ID: 3195179
    [Abstract] [Full Text] [Related]

  • 13. [Quinidine and verapamil combination therapy for the treatment of atrial arrhythmias].
    Kleinebenne A, Mannebach H, Gleichmann U.
    Fortschr Med; 1981 Oct 08; 99(38):1569-74. PubMed ID: 7297996
    [No Abstract] [Full Text] [Related]

  • 14. [Adrenergic beta blockaders and cardiac arrhythmias. Combination propranolol-quinidine in the treatment of chronic atrial fibrillation].
    Milone P, Anselmino A.
    Minerva Cardioangiol; 1974 Sep 08; 22(9):623-33. PubMed ID: 4607995
    [No Abstract] [Full Text] [Related]

  • 15. [Electrophysiological studies on the effect of cordarone].
    Piwowarska W, Sniezek-Maciejewska M, Szczepkowski J.
    Kardiol Pol; 1984 Sep 08; 27(3):181-9. PubMed ID: 6737834
    [No Abstract] [Full Text] [Related]

  • 16. [Anti-arrhythmia agents].
    Kaufmann G.
    Med Klin; 1974 May 03; 69(18):778-86. PubMed ID: 4134645
    [No Abstract] [Full Text] [Related]

  • 17. Clinical electrophysiological properties of penbutolol: a non-selective beta-blocking agent.
    von Leitner ER, Biamino G.
    Eur J Cardiol; 1980 May 03; 12(2):121-8. PubMed ID: 7439238
    [Abstract] [Full Text] [Related]

  • 18. [Management of acute arrhythmias using atenolol in the myocardial-infarct patient].
    Beckmann R, Schley G, Günnewig H.
    Med Welt; 1978 Oct 27; 29(43):1697-9. PubMed ID: 713788
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F.
    Kardiol Pol; 1992 Oct 27; 36(2):92-6. PubMed ID: 1583832
    [No Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic effects of L-penbutolol and DL-propranolol. Comparison of the effects of these two drugs on conductivity and excitability in canine heart in vivo.
    Yamada K, Toyama J, Nimi N, Sugenoya J, Ohno M, Sugiyama S.
    Jpn Heart J; 1979 Sep 27; 20(5):603-11. PubMed ID: 501926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.